Share This Article:

A Patient with Post Infectious Immune Mediated Neuropathy (Miller Fisher Syndrome)

Full-Text HTML XML Download Download as PDF (Size:263KB) PP. 123-127
DOI: 10.4236/ijcm.2017.83011    834 Downloads   1,124 Views


The Miller Fisher variant is an uncommon but well known syndrome being described as a triad of areflexia, ataxia and complex ophthalmoplegia. It is characterized by antibodies against myelin that affects peripheral nerves, extraocular muscles and Schwann cells. Anti-ganglioside antibodies have been recognized in disease pathogenesis and decreasing antibody production is the mainstay of treatment. The course is usually benign with improvement after immunomodulation. This case report describes the approach to a patient suspected of having a demyelinating disorder. It delineates the subsets of immune mediated neuropathies in evaluating the diagnosis and emphasizes the need for early therapeutic intervention in achieving a good clinical outcome.

Cite this paper

Sanchez, S. and Esack, A. (2017) A Patient with Post Infectious Immune Mediated Neuropathy (Miller Fisher Syndrome). International Journal of Clinical Medicine, 8, 123-127. doi: 10.4236/ijcm.2017.83011.

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.